Preliminary application of transesophageal echocardiography in transapical mitral valve repair with Memoclip
10.3760/cma.j.cn131148-20221101-00735
- VernacularTitle:经食管超声心动图在Memoclip经心尖介入二尖瓣夹合手术中的初步应用
- Author:
Haixia LIU
1
;
Xun CHEN
;
Ju MEI
;
Min TANG
;
Jianbing HUANG
;
Yi MENG
;
Fanqiang ZENG
;
Yu CHEN
;
Linyi RAO
;
Hui WANG
;
Yunxia ZHANG
Author Information
1. 合肥高新心血管病医院超声科，合肥 230001
- Keywords:
Echocardiography;
Mitral regurgitation;
Transapical;
Transcatheter;
Mitral valve clamp system
- From:
Chinese Journal of Ultrasonography
2023;32(6):501-507
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the value of transapical catheter of mitral valve repair (MVR) with Memoclip device in the management of moderate to severe and severe mitral regurgitation (MR) guided by transesophageal echocardiography (TEE).Methods:Fifteen patients with moderate to severe and severe MR in Hefei High-tech Cardiovascular Hospital from December 2021 to October 2022 were prospectively selected. Mitral valve morphology and length, regurgitation severity, left ventricular ejection fraction and pulmonary venous Doppler spectra were carefully evaluated before MVR by TEE.Intraprocedural TEE was performed to guide the MVR including transseptal catheterization, alignment of the clip delivery system, assessment of leaflet capture, clip deployment, post-clip deployment assessment, and withdrawal of the clip delivery system. The position and coaptation length of the clips, the mitral orifice morphology, residual mitral valve regurgitation and pressure gradient were evaluated after MVR.Meanwhile, the complications were monitored throughout the procedure.Results:Among the 15 patients, 12 were implanted with 1 clip and 3 were implanted with 2 clips, respectively. No complications occurred. There were 13 patients with mild regurgitation and 2 showed to moderate mitral regurgitation 1 month later after MVR, and 13 remained mild and 2 maintained moderate regurgitation 3 months later. Significant differences were found in maximal MR area (MRA-max), maximal and mean mitral valve pressure gradient (MVPG-max, MVPG-mean) and mitral valve area (MVA) among the 5 observation time points (all P<0.05). MRA-max, MVA and MVPG-mean were significantly decreased immediately and 3 months after the procedure ( P<0.001). No significant stenosis was found in mitral valve after MVR. Conclusions:MVR with Memoclip is safe, effective, easy to operate in treating patients with moderate to severe and severe MR. TEE plays a key role in perioperative MVR with Memoclip through apical catheterization.
